What is EXOZ's interest coverage?

EXOZ (EXOZ) reported interest coverage of -36.1× in Q1 2026.

How has EXOZ's interest coverage changed year-over-year?

EXOZ's interest coverage increased by 41.1% year-over-year, from -61.2× to -36.1×.

What does interest coverage mean?

Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.

EXOZ EXOZ Interest coverage

Interest coverage at other companies

GevoGEVO

-0.3×-0.1×

Ginkgo BioworksDNA

-10.8×—

NAG

Niagen Bioscience, Inc. Common StockNAGE

7.2×-2.7×

Nature's Sunshine ProductsNATR

251×+111×

Opko HealthOPK

-1×-0.4×

West Pharmaceutical ServicesWST

114.2×+46.4×

Other financials

Income statement

See full

Revenue$17.5K—

Operating income-$2.4M-22.4%

Net income-$2.4M-27.7%

EPS (diluted)-$0.28-27.3%

Balance sheet

See full

Cash & equivalents$1.4M-83.0%

Total debt$1.2M-8.8%

Total equity$1.5M-82.8%

Total assets$4.0M-65.1%

Cash flow

See full

Operating cash flow-$1.5M-34.5%

CapEx$57.6K+85.5%

Free cash flow-$1.6M-35.8%

Valuation

See full

Market cap$76.8M-3.3%

Enterprise value$76.57M+3.5%

P/S1,096.1×—

Profitability

See full

Operating margin-14,489.6%—

Net margin-2,909.1%—

FCF margin-10,117.8%—

Returns & leverage

See full

Return on equity-185.8%—

Debt / equity0.8×+0.6×

Current ratio1.3×-5.2×

Where this comes from

Calculated from EXOZ’s reported figures.

ebit/interest expense=-36.1×

Based on trailing twelve months.

The official record: EXOZ’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about EXOZ's interest coverage.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is EXOZ's interest coverage?: EXOZ (EXOZ) reported interest coverage of -36.1× in Q1 2026.
How has EXOZ's interest coverage changed year-over-year?: EXOZ's interest coverage increased by 41.1% year-over-year, from -61.2× to -36.1×.
What does interest coverage mean?: Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.